lycorin
type
isoquinolin
alkaloid
extract
plant
medicin
lycori
radiata
long
use
tradit
chines
recent
studi
show
lycorin
exhibit
effect
importantli
report
lycorin
display
significantli
higher
antiprolif
activ
cancer
cell
normal
thu
could
promis
anticanc
drug
futur
howev
lycorin
poor
solubl
oil
water
would
restrict
clinic
use
therefor
suitabl
formul
lycorin
improv
solubl
appli
futur
clinic
treatment
highli
desir
recent
studi
lipid
nanoemuls
lne
increasingli
attract
attent
lne
nanoscal
oil
water
emuls
central
oil
core
could
stabli
dispers
water
lne
droplet
size
rang
nm
show
narrow
size
due
small
droplet
size
formul
stabl
long
time
sediment
cream
henc
offer
increas
longterm
stabil
make
suitabl
commerci
especi
drug
howev
nontarget
lne
load
lycorin
taken
normal
cell
could
still
caus
undesir
side
effect
target
lne
deliveri
system
specif
would
minim
side
effect
normal
cell
surfac
sugar
modifi
lne
use
tumor
cell
target
due
fact
rapid
prolifer
tumor
cell
increas
need
nutrient
compar
normal
cell
result
overexpress
lectinlik
receptor
encompass
high
affin
polysaccharid
moieti
includ
mannos
galactos
therefor
mannosyl
nanoparticl
target
tumor
cell
due
preferenti
uptak
receptormedi
intern
via
lectin
receptor
surfac
tumor
result
use
mannosyl
lne
carrier
anticanc
drug
lycorin
may
probabl
increas
tumor
cellular
uptak
studi
lycorin
load
mannosyl
lne
prepar
select
drug
deliveri
lung
epitheli
cancer
cell
line
oleic
acid
oa
employ
lipophil
complex
agent
form
lycorineol
acid
ionic
complex
lycoa
order
enhanc
lipophil
lycorin
lycorineol
acid
ionic
complex
lycoa
load
lipid
nanoemuls
lycoaln
well
mannosyl
lycorineol
acid
ionic
complex
load
lipid
nanoemuls
mlycoaln
prepar
solvent
inject
method
vitro
growth
inhibit
activ
cellular
uptak
lycoaln
mlycoaln
investig
use
lung
epitheli
cancer
cell
line
lycorin
puriti
hplc
purchas
hongsheng
plant
materi
co
ltd
sifang
china
oleic
acid
kindli
gift
lipoid
co
ltd
germani
soybean
phospholipid
purchas
taiwei
medic
co
ltd
shanghai
china
soybean
oil
provid
beiya
medic
oil
co
ltd
tiel
china
reagent
trypsin
bromid
mtt
dapi
acquir
sigma
usa
chemic
analyt
grade
better
cho
cell
line
obtain
shanghai
institut
biolog
scienc
sib
shanghai
china
cell
cultur
rpmi
medium
hyclon
usa
supplement
penicillin
streptomycin
calf
serum
minhai
gansu
china
cho
cell
cultur
dmem
medium
hyclon
usa
supplement
penicillin
streptomycin
calf
serum
hyclon
usa
cell
maintain
degre
fulli
humidifi
incub
lycorin
oa
molar
ratio
dissolv
dri
tetrahydrofuran
mgml
solut
maintain
degre
oil
bath
hour
stir
solvent
remov
reduc
pressur
lycorineol
acid
ionic
complex
lycoa
form
order
compar
lipopil
lyc
lycoa
satur
solubl
noctanol
soybean
oil
determin
briefli
lyc
dissolv
noctanol
soybean
oil
respect
lycoa
also
dissolv
noctanol
soybean
oil
respect
agit
hour
thermostat
shaker
bath
degre
equilibr
sampl
centrifug
rpm
degre
minut
supernat
dilut
isopropanol
subsequ
quantifi
excitationemiss
nm
fluoresc
spectrophotomet
pc
shimadzu
kyoto
japan
lycoaln
prepar
solvent
inject
slight
modif
briefli
lycoa
soybean
phospholipid
soybean
oil
dissolv
isopropanol
mgml
degre
compon
molar
ratio
shown
tabl
blend
solut
rapidli
inject
syring
stir
aqueou
phase
room
temperatur
volum
suspens
reduc
rotari
evapor
buchi
swizerland
reduc
pressur
degre
remov
organ
phase
noctadecyldmannosylamin
synthet
purifi
accord
report
slight
modif
octadecylamin
mg
mmol
mannos
mg
mmol
dissolv
ml
menthol
degre
stir
minut
solid
collect
recrystal
ml
ethanol
reaction
scheme
shown
figur
aschem
character
spectral
data
noctadecyldmannosylamin
nmr
mhz
dmso
hz
hz
hz
ms
mz
mh
ms
mz
mna
studi
mlycoaln
also
prepar
solvent
inject
method
describ
section
prepar
lycoaln
mannos
coat
carri
ad
noctadecyldmannosylamin
lipid
matrix
firstli
noctadecyldmannosylamin
lycoa
soybean
phospholipid
soybean
oil
dissolv
isopropanol
mgml
degre
compon
molar
ratio
shown
tabl
blend
solut
rapidli
inject
syring
stir
aqueou
phase
room
temperatur
volum
suspens
reduc
rotari
evapor
buchi
swizerland
reduc
pressur
degre
remov
organ
phase
fluorescein
label
lycorineol
acid
ionic
complex
lipid
nanoemuls
flne
fluorescein
label
mannosyl
lycorineol
acid
ionic
complex
lipid
nanoemuls
fmlne
separ
prepar
solvent
inject
method
describ
section
prepar
lycoaln
prepar
mlycoaln
fluoresc
marker
carri
ad
ww
fluoresceinlabel
pe
deriv
carboxyfluorescein
nfpe
soybean
phospholipid
lipid
matrix
excitationemiss
nm
morpholog
coat
uncoat
lne
examin
transmiss
electron
microscopi
tecnai
fei
holland
sampl
stain
wv
phosphotungst
acid
minut
place
copper
grid
film
view
mean
particl
size
zeta
potenti
coat
uncoat
lne
determin
photon
correl
spectroscopi
malvern
zetas
nano
uk
degre
entrap
effici
coat
uncoat
lne
determin
ultrafiltr
method
previous
separ
free
drug
lne
suspens
centrifug
filtrat
devic
mw
cutoff
kda
pall
life
scienc
usa
use
fix
volum
freshli
prepar
lycoaln
mlycoaln
mgml
separ
ad
sampl
reservoir
tube
spun
rpm
degre
minut
collect
filtrat
dilut
methanol
analyz
fluoresc
spectrophotometri
encapsul
effici
drug
load
calcul
follow
formula
confoc
fluoresc
microscopi
use
observ
intracellular
distribut
coat
uncoat
lne
cell
cultur
hour
steril
glass
coverslip
preimmers
cultur
medium
humidifi
incub
atmospher
cell
expos
concentr
flne
fmlne
fmlne
plu
mgml
mannan
respect
mgml
free
mannan
use
competit
inhibitor
fmlne
hour
incub
medium
remov
cell
wash
pb
time
follow
fix
paraformaldehyd
pb
minut
paraformaldehyd
solut
remov
cell
wash
pb
dapi
pb
ad
well
incub
anoth
minut
last
dapi
solut
remov
cell
wash
pb
time
fluoresc
imag
cell
examin
confoc
microscopi
carl
zeiss
germani
cell
uptak
studi
perform
use
flow
cytometri
analysi
cell
seed
densiti
cell
per
well
ml
medium
sixwel
tissu
plate
corn
ny
usa
incub
hour
humidifi
incub
atmospher
flne
fmlne
mgml
mannan
plu
fmlne
ad
design
well
concentr
ml
incub
hour
well
wash
pb
time
order
remov
lne
taken
cell
cell
trypsin
wv
pellet
centrifug
rpm
wash
cold
pb
remov
trypsin
sampl
examin
flow
cytometri
use
facscan
ariatm
becton
dickinson
san
jose
ca
usa
intracellular
fitc
excit
argon
laser
nm
fluoresc
detect
nm
file
collect
gate
event
analyz
facstat
softwar
program
growth
inhibit
activ
free
lycorin
lycoaln
mlycoaln
mlycoaln
plu
mgml
mannan
perform
use
tetrazolium
bromid
mtt
base
colorimetr
assay
cell
plate
densiti
cell
per
well
medium
plate
hour
humidifi
incub
atmospher
seri
concentr
free
lycorin
lycoaln
mlycoaln
mlycoaln
plu
mgml
mannan
l
respect
blank
lne
ad
differ
well
hour
incub
mtt
solut
mgml
pb
ph
ad
well
sampl
kept
incub
hour
medium
remov
convert
formazan
well
dissolv
dmso
absorb
measur
varioskan
flash
thermo
scientif
usa
nm
cell
viabil
relat
control
well
cell
cultur
medium
calcul
follow
equat
cell
viabil
percentag
od
test
sampleod
neg
control
od
mean
optic
densiti
absorb
optic
element
given
wavelength
per
unit
distanc
experi
repeat
least
three
time
statist
analysi
sampl
perform
use
student
ttest
pvalu
minim
level
signific
lycorin
pyrrolo
de
phenanthridin
ringtyp
alkaloid
fig
poor
solubl
oil
water
obstacl
clinic
applic
studi
aim
increas
lipophil
lycorin
accord
structur
lycorin
method
ionpair
format
could
use
method
use
modifi
lipophil
ioniz
drug
shield
charg
opposit
charg
ion
without
chemic
modif
gener
proton
nitrogen
ring
lycorin
bear
posit
electrostat
charg
carboxyl
group
fatti
acid
provid
neg
charg
consequ
lycorin
fatti
acid
form
ionpair
complex
long
carbon
chain
brought
fatti
acid
enhanc
lipophil
lycorin
studi
oleic
acid
oa
could
employ
counter
ion
biodegrad
physiolog
long
chain
fatti
acid
low
toxic
howev
acid
oa
basic
lycorin
weak
bring
difficulti
form
ionpair
format
complex
format
gener
driven
electrostat
attract
hydrophob
interact
hydrogen
bond
electrostat
forc
domin
interact
polar
molecul
solvent
low
dielectr
constant
favor
ion
pair
studi
tetrahydrofuran
low
dielectr
constant
chosen
solvent
provid
suffici
solubl
lyc
oa
complex
also
facilit
ion
pair
format
addit
littl
water
exist
solvent
ionpair
could
form
may
due
fact
dieletr
constant
water
high
suitabl
ionpair
form
moreov
acid
water
pka
stronger
oleic
acid
pka
thu
condit
water
exist
dissoci
oleic
acid
inhibit
extent
henc
inhibit
ionpair
format
contrari
solvent
dri
first
ionpair
could
form
tetrahydrofuran
type
polar
aprot
solvent
facilit
dissoci
oa
henc
enhanc
acid
carboxyl
ion
oa
attack
proton
nitrogen
lycorin
lycoa
form
postul
structur
ionpair
complex
shown
fig
measur
satur
solubl
organ
solvent
basic
method
evalu
effect
ion
pair
format
lipophil
satur
solubl
noctanol
soybean
oil
lyc
lycoa
shown
lycoa
show
better
satur
solubl
lyc
time
noctanol
time
soybean
oil
respect
indic
higher
lipophil
studi
lycoaln
prepar
solvent
inject
method
mean
lne
prepar
rapidli
inject
solut
lipid
watermisc
solvent
water
method
offer
clear
advantag
use
pharmaceut
accept
organ
solvent
easi
handl
fast
product
process
without
technic
sophist
equip
formul
lycoaln
excipi
oa
soybean
oil
inject
grade
soybean
phospholipid
biodegrad
show
low
toxic
studi
mlycoaln
also
prepar
solvent
inject
method
describ
section
prepar
lycoaln
mannos
coat
perform
ad
noctadecyldmannosylamin
isopropanol
lipid
matrix
first
step
prepar
structur
noctadecyldmannosylamin
suggest
may
amphiphil
mannos
residu
hydrophil
long
carbon
chain
lipophil
therefor
suppos
format
process
nanoparticl
long
carbon
chain
would
insert
lipid
particl
mannos
residu
may
expos
water
postul
structur
nanoparticl
shown
averag
particl
size
zeta
potenti
mlycoaln
lycoaln
shown
tabl
zeta
potenti
import
paramet
determin
stabil
colloid
dispers
absolut
valu
zeta
potenti
coat
uncoat
lne
higher
electrostat
repuls
among
nanoparticl
prevent
coalesc
thu
high
zeta
potenti
indic
good
stabil
lne
addit
neg
charg
observ
possibl
due
distribut
neg
charg
carboxyl
group
surfac
particl
suggest
oa
could
also
act
coemulsifi
result
good
agreement
previou
tem
micrograph
coat
uncoat
lne
shown
fig
mannos
observ
darker
lipid
tem
micrograph
due
higher
densiti
electron
cloud
surfac
particl
fig
darker
fig
may
attribut
mannos
coat
poor
lipophil
drug
hardli
achiev
high
entrap
effici
lne
due
solut
capabl
lipid
matrix
studi
entrap
effici
coat
uncoat
lne
base
lycoa
higher
tabl
contrari
incorpor
lyc
lne
without
complex
lycorin
crystal
would
quickli
dissolv
therefor
aid
form
lycoa
ionpair
complex
lipophil
lyc
enhanc
henc
high
entrap
effici
lne
achiev
drug
load
content
coat
uncoat
lne
shown
tabl
intracellular
distribut
flne
fmlne
observ
confoc
microscopi
cell
line
fig
show
confoc
microscopi
imag
cell
expos
fmlne
fig
flne
fig
fmlne
plu
mgml
mannan
fig
hour
formul
show
green
fluoresc
stain
nuclei
stain
dapi
show
blue
fluoresc
stain
cell
expos
coat
lne
fig
depict
stronger
intracellular
green
fluoresc
intens
expos
uncoat
lne
fig
suggest
mannos
coat
could
caus
cellular
uptak
lne
may
due
fact
uncoat
lne
taken
cell
nonspecif
endocytosi
wherea
mannosyl
lne
taken
receptormedi
endocytosi
cell
incub
coat
lne
plu
mgml
mannan
fig
result
weaker
intracellular
fluoresc
incub
coat
lne
alon
may
due
preferenti
bind
mannan
mannos
receptor
satur
suppress
entri
mannosyl
lne
via
receptormedi
endocytosi
result
suggest
increas
cellular
uptak
coat
lne
attribut
lectin
receptorsmedi
endocytosi
order
quantit
compar
cellular
uptak
fmlne
flne
fmlne
plu
mgml
mannan
cell
cell
uptak
studi
carri
flow
cytometri
method
ww
nfpe
total
lipid
matrix
use
fluoresc
maker
intracellular
fluoresc
intens
directli
proport
amount
nfpe
intern
intracellular
fluoresc
intens
cell
expos
fmlne
flne
fmlne
plu
mgml
mannan
hour
shown
fig
cell
incub
mannosyl
lne
show
higher
fluoresc
intens
incub
uncoat
lne
well
coat
lne
plu
mgml
manna
mean
fluoresc
intens
cell
treatment
respect
may
attribut
receptormedi
endocytosi
follow
intern
nanoparticl
result
agre
studi
intracellular
distribut
formul
confoc
microscopi
fig
show
intracellular
fluoresc
intens
cho
cell
expos
fmlne
flne
hour
mannosyl
lne
could
taken
cho
cell
via
receptormedi
endocytosi
mannos
receptor
express
membran
intracellular
fluoresc
intens
cho
cell
expos
fmlne
flne
show
signific
differ
indic
preferenti
uptak
fmlne
cell
may
attribut
receptormedi
endocytosi
mtt
assay
perform
test
growth
inhibit
activ
free
lycorin
lycoaln
mlycoaln
mlycoaln
plu
mgml
mannan
cell
line
mtt
produc
dark
blue
formazan
product
incub
live
cell
dmso
dissolv
product
show
blue
color
number
live
cell
hour
incub
directli
proport
intens
blue
color
measur
quantit
spectrophotometri
surviv
curv
cell
show
concentr
rang
inhibit
percentag
increas
concentr
lyc
either
free
form
incorpor
lne
increas
inhibit
percentag
show
trend
mlycoaln
lycoaln
free
lyc
concentr
lyc
show
wors
activ
may
due
poor
lipophil
limit
cellular
uptak
wherea
make
lycoa
ionpair
lipophil
lyc
enhanc
incorpor
lipid
nanoemuls
inhibit
activ
lycoaln
accordingli
better
lyc
mlycoaln
show
best
activ
may
due
mannos
nanoparticl
promot
better
intern
lectin
receptor
cell
henc
enhanc
cellular
uptak
result
consist
studi
intracellular
distribut
formul
confoc
microscopi
well
cell
uptak
studi
flow
cytometri
addit
blank
lne
exhibit
even
nontox
variou
concentr
suggest
lipid
matrix
lne
use
studi
well
toler
formul
concentr
moreov
concentr
rang
inhibit
rate
mlycoaln
plu
mgml
mannan
close
lycoaln
indic
receptormedi
endocytosi
mlycoaln
suppress
competit
inhibit
effect
mgml
mannan
high
drug
concentr
inhibit
activ
mlycoaln
plu
mgml
mannan
close
mlycoaln
probabl
interpret
exist
high
concentr
coat
lne
compromis
competit
inhibit
effect
mgml
mannan
thu
receptormedi
endocytosi
mlycoaln
suppress
inhibit
concentr
lyc
lycoaln
mlycoaln
shown
tabl
mlycoaln
show
signific
higher
lycoaln
p
also
lycoaln
show
signific
higher
lyc
p
mlycoaln
could
promis
formul
tumor
target
deliveri
lyc
parenter
administr
first
excipi
oa
soybean
oil
low
toxic
clinic
avail
parenter
secondli
lne
alreadi
use
drug
deliveri
system
administr
intraven
inject
purpos
nutrit
eg
administr
fat
deliveri
vaccin
gene
carrier
control
drug
releas
target
drug
specif
site
either
hepat
system
tumor
organ
nanoemuls
advantag
intraven
administr
strict
requir
rout
administr
especi
necess
formul
droplet
size
lower
although
lectin
receptor
also
express
cell
rather
tumor
cell
eg
dendrit
cell
sugar
modifi
lne
could
still
target
tumor
site
nanoformul
passiv
accumul
tumor
tissu
though
epr
effect
follow
lectin
receptor
mediat
tumor
cell
uptak
govind
pagraw
group
demonstr
use
noctadecyldmannosylamin
mannos
coat
nanoparticl
drug
deliveri
system
facilit
deliveri
anticanc
drug
tumor
site
reduc
access
normal
addit
vitro
experi
current
studi
prove
increas
tumor
cell
uptak
tumor
cell
growth
inhibit
activ
coat
format
compar
lyc
uncoat
one
suggest
particl
ferri
lyc
select
tumor
tissu
reduc
side
effect
use
futur
clinic
studi
mannosyl
lipid
nanoemuls
formul
load
lycorineol
acid
complex
prepar
lycorineol
acid
ionic
complex
made
lipophil
lyc
greatli
improv
facilit
high
entrap
effici
formul
mannosyl
augment
cellular
uptak
growth
inhibit
activ
lycorin
lipid
nanoemuls
cell
line
indic
target
deliveri
lycorin
tumor
tissu
may
achiev
develop
mannosyl
lipid
nanoemuls
may
use
deliveri
carrier
drug
imag
probe
potenti
appli
diagnosi
treatment
cancer
